Nothing wrong with locking down an eighteen per cent profit for just a few days investment, AD. Nice win! I'm in for the long run, including the multiple catalysts ahead: DEA designation, Milestone Payments, new distributors/territories, media blitz, revs, short squeeze, pipeline and always potential of big pharma buyout! http://stockcharts.com/h-sc/ui?s=ARNA
Those discouraging articles were HF plants- they are trapped short and desperate (and unscrupulous).
Market Data 
Markets 
AI
